IRCT201107145943N3已完成未知
Evaluation the effect of Mitoxantrone and Mitoxantrone plus Methylprednisolone on Progressive Multiple Sclerosis
Yazd University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 50 years（—）
- 性别
- All
入选标准
- •presence of progressive MS, age between 20 to 50
- •Exclusion criteria: Age below 20 or above 50, Immune deficiency, cancer, Pregnancy or breast feeding, Renal or heart failure, Leukopenia during the injection (the reduction of neutrophils to less than 1500/ml), having received corticosteroids within 6 months before the trial
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic LymphomasLymphoma, Non-HodgkinHIV InfectionsNCT00002003Lederle Laboratories
Unknown
2 期
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic CancerAdvanced Pancreatic CancerNCT05100329CSPC ZhongQi Pharmaceutical Technology Co., Ltd.38
进行中（未招募）
不适用
ADMIRE: Does the ADdition of Mitoxantrone Improve REsponse to FCR chemotherapy in patients with CLL: A randomised Phase II Trial of fludarabine, cyclophosphamide and rituximab (FCR) with or without mitoxantrone (M) in previously untreated chronic lymphocytic leukaemia - ADMIREEUCTR2008-006342-25-GBeeds Teaching Hospitals NHS Trust
已完成
2 期
Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)Androgen-independent Prostate CancerNCT00661492US Oncology Research115
已完成
不适用
The effect of methylprednisolon plus mitoxantrone in the treatment of progressive multiple sclerosisMultiple sclerosisMultiple sclerosis.IRCT201012245393N1Shahid Sadooghi University of Medical Sciences and Health Services36